Cramer: Buy Vistra, Even as It’s a Falling Knife
TL;DR
In Mad Money’s Lightning Round, Jim Cramer says Vistra has pulled back after a run-up and labels it a falling knife, but would still buy with a cautious 25% position; he also weighs in on FICO, Clover Health, and Stryker.
Want the full story? Read the original reporting
Read on CNBC